Novo Nordisk's Karsten Munk Knudsen is targeting 800 million obese people globally.

Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales of popular weight-loss drug Zepbound after it last month forecast lower-than ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

The doctor looked at the results from my blood test, considered them for a moment, and then turned to me. “These should be lower,” she said definitively. “Much lower.” The rows of numbers blurred ...